FDA confirms tirzepatide shortage is over, gives compounders a grace period
The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put a stop to companies making cheaper copies.
The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put a stop to companies making cheaper copies.
In this analysis, investigators conducted a systematic review of studies evaluating the effects of smoking tobacco on surgical outcomes for those with hidradenitis suppurativa.
NTT Corporation (NTT) published analysis from its top global cybersecurity executives and experts on five major trends expected to shape the cybersecurity landscape in 2025…
In a Q and A, the epidemiologist Michael Osterholm acknowledges concerns about vaccines and encourages more openness on risks as well as benefits.
Explore this post and more from the gadgets community
Hospital radio is evolving from offering companionship on the wards to bringing health and wellbeing broadcasting to the community, finds Richard Hurley General practitioner (GP)…
The state raised the minimum wage for fast-food workers—and employment kept rising. So why has the law been proclaimed a failure?
MIT researchers developed a biosensing technique that eliminates the need for wires. Instead, tiny, wireless antennas use light to detect minute electrical signals in the…
Joy Ryan, known as ‘Grandma Joy,’ got her first passport at 91 years old as part of her journey to become the oldest person to…
Check out who’s buying and selling in this week’s roundup of healthcare mergers, acquisitions and joint ventures.
Does a genetic secret explain why a devastating form of kidney disease affects Black Americans?